Incidence of Cardiovascular Diseases in Patients With Hypopituitarims

Cardiovascular Diseases Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00442858
• Other study ID #: LU-286-99
• Status: Completed
• Phase: N/A
• First received: March 1, 2007
• Last updated: March 1, 2007
• Start date: January 1999
• Est. completion date: December 2002

Study information

• Verified date: March 2007
• Source: Lund University Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Sweden: Ethics Committees at Lund University Hospital
• Study type: Observational

Clinical Trial Summary

The aim of the present study was therefore two-fold: 1) to make a retrospective comparison of incidence of non-fatal stroke and cardiac events between a large cohort of patients with confirmed GHD on replacement therapy (including GH) and a control cohort from the general population; 2) to compare the prevalence of DM and cardioprotective medication between the cohorts at the time of questionnaire distribution with adjustment for possible confounders and effect modifiers.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 800
• Est. completion date: December 2002
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Confirmed GH deficiency

Exclusion Criteria:

• Not confirmed GH deficiency

Study Design

Observational Model: Defined Population, Time Perspective: Longitudinal

Related Conditions & MeSH terms

• Cardiovascular Diseases

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Lund University Hospital